The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Offer of Subscription

6 Mar 2020 14:56

RNS Number : 3282F
Baronsmead Second Venture Trust PLC
06 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Second Venture Trust plc

6 March 2020

Update on the Offer for Subscription

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a Prospectus in conjunction with Baronsmead Venture Trust plc in relation to an offer for subscription to each raise up to £20 million (before costs) with an over-allotment facility to each raise up to a further £5 million (the "Offer").

On 27 February 2020 the Company carried out a third allotment of shares under the Offer, issuing 2,318,288 new ordinary shares of 10 pence each in the Company ("New Shares"). Subsequently, at the annual general meeting of the Company held on 27 February 2020, shareholders approved the payment of a final dividend of 3.5 pence per share (the "Final Dividend"). However, the net asset value as at 31 January 2020 did not take account of the Final Dividend and accordingly the net asset value used to calculate the issue price which the New Shares were issued at was overstated by the amount of the Final Dividend.

On the basis of the adjusted net asset value the Company has issued an additional 101,155 New Shares resulting in 2,419,443 New Shares being issued in the third allotment under the Offer at an issue price of 82.50 pence.

Applications have been made for the additional New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the additional New Shares to be issued pursuant to the Offer at 8.00 a.m. on 11 March 2020.

Share certificates and tax certificates in respect of the original issue of New Shares have not yet been issued. It is expected that share certificates and tax certificates showing the aggregate number of New Shares issued will be sent to the relevant Shareholders within 10 business days of the date of the allotment of the additional New Shares.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of additional New Shares pursuant to the Offer, the Company will have 268,014,594 Ordinary Shares in issue (of which 22,750,063 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 245,264,531 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEZQLFBBXLEBBZ
Date   Source Headline
24th May 20175:00 pmRNSTransaction in Own Shares
24th May 20177:00 amRNSHalf-year Report
5th May 20174:00 pmRNSNet Asset Value(s)
18th Apr 20173:30 pmRNSNet Asset Value(s)
23rd Mar 20173:01 pmRNSResult of AGM
14th Mar 20179:16 amRNSDirector Declaration
6th Mar 201711:00 amRNSNet Asset Value(s)
2nd Mar 20177:00 amRNSDividend Declaration
6th Feb 201712:00 pmRNSNet Asset Value(s)
19th Jan 201710:00 amRNSNet Asset Value(s)
3rd Jan 20172:00 pmRNSTotal Voting Rights
14th Dec 20164:01 pmRNSTransaction in Own Shares
6th Dec 20164:00 pmRNSNet Asset Value(s)
30th Nov 20162:45 pmRNSIssue of Equity
28th Nov 20161:00 pmRNSNet Asset Value(s)
24th Nov 20162:30 pmRNSPublication of Supplementary Prospectus
17th Nov 20167:00 amRNSNet Asset Value(s)
17th Nov 20167:00 amRNSAnnual Financial Report
8th Nov 20164:36 pmRNSResult of General Meeting
17th Oct 20164:52 pmRNSMerger Update
14th Oct 20163:00 pmRNSNet Asset Value(s)
12th Oct 20163:19 pmRNSDirectorate Change
3rd Oct 20162:50 pmRNSTotal Voting Rights
29th Sep 20165:15 pmRNSTransaction in Own Shares
26th Sep 20164:00 pmRNSNet Asset Value(s)
6th Sep 20163:30 pmRNSNet Asset Value(s)
24th Aug 20167:00 amRNSDividend Declaration
19th Aug 201610:30 amRNSNet Asset Value(s)
19th Aug 20167:00 amRNSHalf-year Report
11th Aug 20165:30 pmRNSProposed Merger
9th Aug 20165:59 pmRNSChange of accounting reference date
1st Jul 201610:17 amRNSTotal Voting Rights
29th Jun 20164:56 pmRNSTransaction in Own Shares
6th Jun 20164:28 pmRNSNet Asset Value(s)
1st Jun 20164:24 pmRNSTransaction in Own Shares
24th May 20165:11 pmRNSNet Asset Value(s)
24th May 20164:53 pmRNSNet Asset Value(s)
12th May 201612:14 pmRNSDividend Declaration
19th Apr 20165:05 pmRNSResult of AGM
1st Apr 20163:16 pmRNSTotal Voting Rights
30th Mar 20165:48 pmRNSTransaction in Own Shares
15th Mar 20165:01 pmRNSChange of Name
15th Mar 20163:42 pmRNSIssue of Equity
11th Mar 20164:49 pmRNSIssue of Equity
10th Mar 20165:03 pmRNSPublication of Supplementary Prospectus
4th Mar 20164:57 pmRNSNet Asset Value(s)
3rd Mar 20165:12 pmRNSResult of General Meeting
2nd Mar 20162:43 pmRNSDirector Declaration
25th Feb 201611:03 amRNSDisclosure of Home Member State
24th Feb 201610:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.